Cancer Family
Central Nervous System Neoplasm
CI-CAN-00000118Explore in graph →
Non-malignant1,345 active trials7 approved drugs177 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000118Explore in graph →
Clinical trials
5,060 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06222138 | Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma(EXOFIELDS) | recruiting | N/A | 80 | Institut Claudius RegaudOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT06442748 | Short Versus Long-term Levetiracetam in Brain Tumors(LIBRA) | recruiting | Phase 3 | 604 | Tata Memorial CentreOTHER | 1 | Feb 13, 2026 |
| clinicaltrials |
| NCT07263438 | Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial(Phenix) | recruiting | Phase 2 | 59 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT07410520 | PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL. | recruiting | Phase 2 | 50 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT05957679 | MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment | recruiting | N/A | 20 | Shengjing HospitalOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06955208 | 3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features | recruiting | N/A | 300 | Shengjing HospitalOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07402876 | A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma | recruiting | Phase 3 | 20 | Aldeyra Therapeutics, Inc.INDUSTRY | 1 | Feb 11, 2026 | clinicaltrials |
| NCT06132685 | Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial | recruiting | Phase 2 | 200 | Emory UniversityOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT04706910 | 18F-DOPA II - PET Imaging Optimization | recruiting | Phase 3 | 800 | University of AlbertaOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT05890781 | Engineering Immune Organoids to Study Pediatric Cancer(IMMUNEORGANOID) | recruiting | N/A | 108 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT07396896 | KETO-TUMOR: a Study on Brain Tumors and Central Obesity | recruiting | N/A | 30 | Meyer Children's Hospital IRCCSOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT05139277 | Evaluation of the CONVIVO System | recruiting | N/A | 30 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT05700721 | Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET) | recruiting | Phase 2 | 120 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT06117930 | Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research | recruiting | — | 100 | Mayo ClinicOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT06650163 | Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors | recruiting | Phase 1 | 20 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07391215 | 5G-PEARL: Paxalisib in Malignant Brain Tumours(5G-PEARL) | recruiting | Phase 1 / Phase 2 | 64 | Institute of Cancer Research, United KingdomOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT05653622 | Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma(SIB-DOPA) | recruiting | Phase 2 | 75 | Centre Paul StraussOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT05653635 | Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study(ReciDOPA) | recruiting | Phase 2 | 54 | Centre Paul StraussOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT05756985 | Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue | recruiting | — | 120 | Baptist Health South FloridaOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT05331521 | A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).(ImproveCodel) | recruiting | Phase 3 | 406 | University Hospital HeidelbergOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT06470711 | Mapping of Electrical Properties in the Brain | recruiting | — | 120 | Mayo ClinicOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT02394626 | Surgery for Recurrent Glioblastoma(RESURGE) | recruiting | Phase 2 | 120 | Insel Gruppe AG, University Hospital BernOTHER | 9 | Feb 2, 2026 | clinicaltrials |
| NCT05464992 | Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI(GlioCEST) | recruiting | N/A | 800 | Centre Paul StraussOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07381959 | Biomarkers of Brain Injury in Children With Brain Tumors(BiomarkCBT) | recruiting | — | 560 | Uppsala UniversityOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT05683808 | Venous Thromboembolism Prevention in Outpatients With Glioma(VTE-POG) | recruiting | Phase 2 | 40 | University of Vermont Medical CenterOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT07272616 | Detection of Brain Metastases Using a Novel Gadolinium-Weighted MRI Sequence: A Prospective Comparison(GDW) | recruiting | — | 100 | Region StockholmOTHER_GOV | 1 | Jan 30, 2026 | clinicaltrials |
| NCT07338526 | Intensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT)(IMPORT) | recruiting | N/A | 94 | Tata Memorial CentreOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT07378683 | A Clinical Prediction Model for Surgical Site Infection After Central Nervous System Tumor Surgery | recruiting | N/A | 500 | Ming YangOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT03324360 | Role of Hyperpolarized 13C-Pyruvate MR Spectroscopy in Patients With Intracranial Metastasis Treated With (SRS) | recruiting | Phase 1 | 276 | Sunnybrook Health Sciences CentreOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT04702581 | A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery(POLO) | recruiting | Phase 3 | 280 | Hospices Civils de LyonOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT06280300 | Multi-disciplinary Care for Brain Metastases | recruiting | N/A | 40 | University of Vermont Medical CenterOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT03526822 | Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.(MM-Predict) | recruiting | N/A | 100 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT05762419 | FUS Etoposide for DMG | recruiting | Phase 1 | 10 | Columbia UniversityOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT06208657 | Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer | recruiting | Phase 1 / Phase 2 | 90 | Australian & New Zealand Children's Haematology/Oncology GroupOTHER | 2 | Jan 28, 2026 | clinicaltrials |
| NCT04865315 | A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors(HiLoGlio) | recruiting | — | 50 | Maastricht Radiation OncologyOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT05102747 | Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation.(OligoBM-01) | recruiting | N/A | 504 | Centre Francois BaclesseOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT04196413 | GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG) | recruiting | Phase 1 | 97 | Stanford UniversityOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT05556473 | F-Tryptophan PET/CT in Human Cancers | recruiting | Phase 1 | 24 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07364786 | Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma(AFGBMBiop) | recruiting | Phase 2 | 10 | Peter SiesjöOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT05084430 | Study of Pembrolizumab and M032 (NSC 733972) | recruiting | Phase 1 / Phase 2 | 28 | University of Alabama at BirminghamOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT07143812 | A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma | recruiting | Phase 1 | 10 | CHA UniversityOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT07268183 | How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors(OEMacroPrL) | recruiting | — | 180 | Hospices Civils de LyonOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT06630260 | 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours(5G-RUBY) | recruiting | Phase 1 / Phase 2 | 182 | Institute of Cancer Research, United KingdomOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05366881 | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease(CAMPERR) | recruiting | — | 7,000 | Adela, IncINDUSTRY | 1 | Jan 20, 2026 | clinicaltrials |
| NCT05571579 | Biological Collection of Brain Tumors(GLIOLI) | recruiting | — | 500 | Hospices Civils de LyonOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT06625684 | Key Longitudinal Associations With Risk and Glioblastoma Outcomes(Key LARGO) | recruiting | — | 200 | Duke UniversityOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT03144167 | Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy(SPECTROBEVA) | recruiting | N/A | 170 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT06752096 | Robot-Assisted Neurovascular Intervention | recruiting | N/A | 10 | Navigantis Inc.INDUSTRY | 1 | Jan 16, 2026 | clinicaltrials |
| NCT07339085 | Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis | recruiting | N/A | 42 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT00811148 | Florida Center for Brain Tumor Research(FCBTR) | recruiting | — | 4,000 | University of FloridaOTHER | 1 | Jan 13, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Feb 13, 2026source: clinicaltrials